Thus, Priolo and coworkers have shown that prostate cancer associated with predominant MYC overexpression display dysregulated lipid metabolism, while tumors with predominant AKT1 activation were associated with accumulation of aerobic glycolysis metabolites [279]. The gene discussed is MYC; the disease is prostate cancer.